Dr Reddys Laboratories Ltd Share Price Today - Live Blog for February 17, 2026

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 1.23% uptick in its share price. As a result, it's now actively trading at 1285.00 per share, making it an attractive option for investors.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 1.23%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of 1285.00 per share.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.92% recently. As of now, this stock is actively trading at a current market price of 1281.10 per share, attracting attention from investors.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.92% increase and currently trading at 1281.10 per share. Investors are taking notice of this upward momentum.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.75% increase. Presently, it is actively trading at 1278.90.

Dr Reddys Laboratories Ltd's stock price surged by 0.75%, reaching the current market value of 1278.90 per share. This surge is a testament to the stock's recent performance.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.02% in its share price, and it currently trades at 1269.20 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has dropped by -0.02%, a development that warrants careful analysis. Presently trading at 1269.20, investors are assessing whether this presents an opportunity or a risk.

With a -0.34% decrease, Dr Reddys Laboratories Ltd's share price is now 1265.10. Investors should examine the factors driving this decline. The stock's PE ratio is 22.8300, whereas the industry PE ratio stands at 39.7541.

Dr Reddys Laboratories Ltd observed a -0.34% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1265.10. The stock has a PE ratio of 22.8300, an ROE of 17.1316 and a debt to equity ratio of 0.1263.

Dr Reddys Laboratories Ltd's share price has fallen by -0.27%, presenting both challenges and opportunities for investors. As of now, it's trading at 1266.00, and market participants are assessing the implications. The stock has a PE ratio of 22.8300, an ROE of 17.1316 and a debt to equity ratio of 0.1263.